miércoles, 12 de enero de 2011

CDC - Mercury and Thimerosal - Vaccine Safety

Thimerosal
Information about Thimerosal
Since 2001, with the exception of some influenza (flu) vaccines, thimerosal is not used as a preservative in routinely recommended childhood vaccines.

Thimerosal is a mercury-containing preservative used in some vaccines and other products since the 1930's. There is no convincing evidence of harm caused by the low doses of thimerosal in vaccines, except for minor reactions like redness and swelling at the injection site. However, in July 1999, the Public Health Service agencies, the American Academy of Pediatrics, and vaccine manufacturers agreed that thimerosal should be reduced or eliminated in vaccines as a precautionary measure.


Information about Thimerosal
Since 2001, with the exception of some influenza (flu) vaccines, thimerosal is not used as a preservative in routinely recommended childhood vaccines.


Vaccines and Thimerosal

•CDC Study on "Prenatal and Infant Exposure to Thimerosal from Vaccines and Immunoglobins and Risk of Autism" (2010)
[CDC - Exposure to Thimerosal from Vaccines & Immunoglobins - Vaccine Safety]



•CDC Study on "Infant and Environmental Exposures to Thimerosal and Neuropsychological Outcomes at Ages 7 to 10 Years" (2007)
[CDC - Thimerosal & Neuropsychological Outcomes at Ages 7–10 Years - Vaccine Safety]



•CDC: Immunization Safety and Autism - Thimerosal and Autism Research chart [PDF - 30 KB]
http://www.cdc.gov/vaccinesafety/00_pdf/VSD_Chart_of_Autism_Studies-Updated_Sep_27_2010.pdf


•Frequently Asked Questions about Thimerosal
CDC - Thimerosal FAQs -Vaccine Safety



•Timeline: Thimerosal in Vaccines (1999-2008)
CDC - Thimerosal Timeline - Vaccine Safety



•Measles, Mumps, and Rubella (MMR) Vaccine
CDC - MMR Index - Vaccine Safety


Related Research

► Centers for Disease Control and Prevention. Recommendations regarding the use of vaccines that contain thimerosal as a preservative. MMWR 1999:48(43);996-998. [Recommendations Regarding the Use of Vaccines That Contain Thimerosal as a Preservative]


► McMahon AW, Iskander JK, Haber P, Braun MM, Ball R. Inactivated influenza vaccine (IIV) in children < 2 years of age: Examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal-free or thimerosal-containing vaccine. Vaccine 2008;26(3):427–429. [Inactivated influenza vaccine (IIV) in children 2... [Vaccine. 2008] - PubMed result]


Thompson WW, Price C, Goodson B, Shay DK, Benson P, Hinrichsen VL, Lewis E, Eriksen E, Ray P, Marcy SM, Dunn J, Jackson LA, Lieu TA, Black S, Stewart G, Weintraub ES, Davis RL, DeStefano F; Vaccine Safety Datalink Team. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. New England Journal of Medicine 2007;357(13):1281–1292. [Early thimerosal exposure and neuropsychological o... [N Engl J Med. 2007] - PubMed result]


full-text:
CDC - Mercury and Thimerosal - Vaccine Safety

No hay comentarios:

Publicar un comentario